ArticleWorld journal of diabetes2021

Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes.

Eiji Kawasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.